Healthcare Global Enterprises Fund Raise of ₹424.7 Cr

Healthcare Global Enterprises Other Announcement

HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Healthcare Global Enterprises Board Meeting Date

HealthCare Global Enterprises will hold a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.

Healthcare Global Enterprises Acquisition Worth ₹0 Cr

Healthcare Global's subsidiary, HCG Kenya, increased its stake in Advanced Molecular Imaging Limited (AMIL) to 50.10% by acquiring additional shares for approximately ₹0.003 Crore.

Value

₹0.00 Cr

Healthcare Global Enterprises Other Announcement

The company clarified discrepancies in shareholding pattern filings, attributing differences to the timing of corporate actions following a rights issue and NDU disclosure variances.

Healthcare Global Enterprises Acquisition

Healthcare Global's subsidiary acquired an additional 0.10% stake in Advanced Molecular Imaging Limited for INR 0.00 Crore, making it a subsidiary of the company.

Healthcare Global Enterprises Other Announcement

Designated person Ashwini P Kavadimatti disclosed a pledge creation of 5,000 shares and a market sale of 500 shares of HealthCare Global Enterprises Ltd.

Value

₹0.38 Cr

Amba Auto Sales and Services Fund Raise of ₹161.6 Cr

Amba Auto board approved a preferential issue of up to 1.60 crore warrants at Rs 101 each. The issue aggregates Rs 161.60 Crore, subject to shareholder approval.

Value

₹161.6 Cr

Jindal Capital Fund Raise of ₹16.22 Cr

Jindal Capital's board approved a rights issue of 1,08,12,149 shares at Rs.15 each, raising Rs.16.22 Crore. The issue ratio is 3:2, with record date 06 November 2026.

Value

₹16.22 Cr

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value

₹187.2 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr